GlassScriptPhysician profile
Paul R Brown
NPI 1508040312
$2,533.16
in general payments reported to CMS, 2019-2025
9 companies · $1,477 in 2025
The $1,477 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $58.27 · 2023: $25.19 · 2024: $815 · 2025: $1,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,609 · Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,609.07 |
| Food and Beverage | $707.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,772.60 | 2024-2025 | Ribfix Titan, Advantagerib |
| Atricure, INC. | $483.13 | 2021-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System, Synergy Ablation System |
| Davol INC. | $144.52 | 2025 | Progel Applicator Spray Tips |
| Edwards Lifesciences Corporation | $43.91 | 2022-2024 | Mitris Resilia Mitral Valve |
| W. L. Gore & Associates, INC. | $22.95 | 2022 | |
| Abiomed | $22.31 | 2025 | |
| Abbott Laboratories | $21.25 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Solventum Corporation | $18.82 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Cvrx, INC. | $3.67 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.